Cystoscopy at 5 months revealed that most of the right side of the bladder was covered with necrotic tissue and the right ureteral orifice could not be identified; gradually, the observations became more prominent (Fig. 1). Right hydrou...
Additionally, the majority of studies did not comment on the use of enhanced cystoscopy which has been shown to improve cancer detection rates, particularly CIS. Moreover, other factors such as the extent of follow-up and scrutiny o...
At the conclusion of the 6-weekcourse, the patient undergoes a cystoscopy.If the bladder is free of tumorrecurrence, then the patient is enteredinto a program of regular cystoscopic follow-up. If the tumor recurs, then thepatient can, after resection, have a furthercourse of BCG.3Side Effe...
Research has shown that maintenance treatment can reduce the risk of tumours growing back in the bladder.Following your check cystoscopy (after your first course of treatment), maintenance treatment will be started within one month. This is usually given as a course of three BCG treatments (one ...
This video episode discusses various new therapies and strategies for treating patients with high-risk BCG-unresponsive NMIBC. It includes a review of nadofaragene firadenovec-vncg, its FDA approval, dosing schedule, and patient response rates. The conve
Natural language processing (NLP) was used to identify TURBT pathology reports, using the search term bladder, as well as other key words indicative of a TURBT, including transurethral and cystoscopy. The TURBT pathology reports were categorized as benign or malignant based on a combination of ...
請多休息請戒煙,因吸煙是誘發膀胱癌的主因。請多飲水,除非醫生禁止,否則應在灌注後24小時內飲用大量液體2-3公升(8-12杯250毫升)如需要時請按時服用醫生處方的抗生素或..
Background It is not known how long follow-up cystoscopy in tumour-free bacillus Calmette-Guérin (BCG)–treated patients should continue. Objective Determ... Sten,Holmäng,and,... - 《European Urology》 被引量: 23发表: 2012年 Bacillus Calmette‐Guérin therapy in stage Ta/T1 bladder cancer...
Evaluation for efficacy consisted of cystoscopy and urine cytology at 3-month intervals with a mandatory biopsy occurring at 12 months after first installation. The primary end point was the CR rate in patients with carcinoma in situ at any time after first receiving therapy. Secondary outcome meas...
We followed 25 patients out to the 12-month mark, which is the primary end point of the study, to assess for the CR rate as assessed by random bladder biopsies, cystoscopy, and urine cytology. Of these 25 patients, 68% achieved a durable CR at the 1-year timeframe. In addition, ...